Drug
Fluocinolone Acetonide clinical trials
Also written ILUVIEN and Retisert.
Keep track of what changes. Save the Fluocinolone Acetonide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
29 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 11
Alimera Sciences (8) · Bausch & Lomb Incorporated (5) · Galderma R&D (2) · Sanjay Asrani (1) · Texas Retina Associates (1) · LEO Pharma (1) · EyePoint Pharmaceuticals, Inc. (1) · Glenn Jaffe (1)
Often tested with
Tested in the same studies.
LEO 90100 (1) · Betamethasone dipropionate, calcipotriol drug combination (1) · Clobetasol (1) · Faricimab (1)
Studies
Open first, then newest update. How each study uses Fluocinolone Acetonide is read from its arms, and is right about nine times in ten.
Testing it · 29
- Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation RetinopathyRecruitingPhase 3Jaeb Center for Health ResearchNCT05844982Written as fluocinolone acetonide
- Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular OedemaRecruitingPhase 4Centre Hospitalier Universitaire DijonNCT04910503Written as Fluocinolone Acetonide Intravitreal Implant
- The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentCompletedPhase 3Texas Retina AssociatesNCT05486468Written as Yutiq 0.18 MG Drug Implant
- A Study of Yutiq Steroid Insert During Glaucoma Tube Implant SurgeryActive, not recruitingEarly Phase 1Sanjay AsraniNCT04918121Written as Yutiq 0.18 MG Drug Implant
- A Vasoconstriction Study With LEO 90100CompletedPhase 1LEO PharmaNCT01946386Written as Synalar® ointment
- A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)Active, not recruitingPhase 4Alimera SciencesNCT04469595Written as Iluvien 0.19 MG Drug Implant
- Combined Ranibizumab and Iluvien for Diabetic Macular OedemaWithdrawnPhase 2/3Imperial College LondonNCT03784443Written as Iluvien 0.19 MG Drug Implant
- Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in MelasmaTerminatedPhase 4Galderma R&DNCT00669071Written as Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%
- Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for MelasmaCompletedPhase 4Galderma R&DNCT00472966Written as Fluocinolone acetonide 0.1%/hydroquinone 4%/tretinoin 0.05% Cream in sequence with glycolic acid peels
- Phase 4 IOP Signals Associated With ILUVIEN®CompletedPhase 4Alimera SciencesNCT02424019Written as ILUVIEN 0.19 MG
- Steroids for Early Treatment of Radiation RetinopathyWithdrawnPhase 2/3The Cleveland ClinicNCT03238157Written as Fluocinolone Acetonide (FA) implant
- Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior UveitisCompletedPhase 3EyePoint Pharmaceuticals, Inc.NCT02746991Written as FAI Insert
- Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or PanuveitisCompletedPhase 1Glenn JaffeNCT01781936Written as Fluocinolone Acetonide
- Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) StudyWithdrawnPhase 4Johns Hopkins UniversityNCT02902744Written as ILUVIEN®
- A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema PatientsCompletedPhase 4Association for Innovation and Biomedical Research on Light and ImageNCT02359526Written as IlUVIEN
- A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid TherapyCompletedPhase 4Alimera SciencesNCT02472366Written as ILUVIEN
- Fluocinolone Acetonide Intravitreal Inserts in Geographic AtrophyTerminatedPhase 2Alimera SciencesNCT00695318Written as Fluocinolone Acetonide
- Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in RetinaTerminatedPhase 2Alimera SciencesNCT00770770Written as Fluocinolone Acetonide
- Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension StudyCompletedPhase 3Alimera SciencesNCT01304706Written as Fluocinolone Acetonide
- Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior SegmentCompletedPhase 4Duke UniversityNCT00543296Written as 0.59 mg Fluocinolone Acetonide implant
Codes
What other systems call Fluocinolone Acetonide · ClinicalTrials.gg INT007504
- MeSH (NLM) D005446Fluocinolone AcetonideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0CD5FD6S2MFLUOCINOLONE ACETONIDEConfirmed FDA, NLM, Wikidata
- RxNorm 4461Confirmed FDA, Wikidata
- Wikidata Q924467fluocinolone acetonideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29055Fluocinolone AcetonideOne source FDA
- DrugBank DB00591One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005446 | Fluocinolone Acetonide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0CD5FD6S2M | FLUOCINOLONE ACETONIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4461 | — | Confirmed FDA, Wikidata |
| Wikidata | Q924467 | fluocinolone acetonide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29055 | Fluocinolone Acetonide | One source FDA |
| DrugBank | DB00591 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.